BATS | ETF
The fund is an actively-managed exchange-traded fund (ETF) that will invest under normal circumstances primarily (at least 80% of its assets) in domestic and foreign equity securities of companies across multiple sectors, including healthcare, information technology, materials, energy and consumer discretionary, that are relevant to the fund's investment theme of the genomics revolution (Genomics Revolution Companies).
It is non-diversified.
Top 20 Holdings
| Asset | Name | Sector | Industry | Weight |
|---|---|---|---|---|
| TEM | Tempus AI, Inc. Class A Common Stock | Healthcare | Health Information Services | 9.23% |
| CRSP | Crispr Therapeutics AG | Healthcare | Biotechnology | 9.19% |
| TWST | Twist Bioscience Corp | Healthcare | Diagnostics & Research | 8.47% |
| PSNL | Personalis Inc | Healthcare | Diagnostics & Research | 5.72% |
| BEAM | Beam Therapeutics Inc | Healthcare | Biotechnology | 5.15% |
| TXG | 10X Genomics Inc | Healthcare | Health Information Services | 5.15% |
| GH | Guardant Health Inc | Healthcare | Diagnostics & Research | 4.74% |
| NTRA | Natera Inc | Healthcare | Diagnostics & Research | 4.16% |
| ILMN | Illumina Inc | Healthcare | Diagnostics & Research | 3.88% |
| RXRX | Recursion Pharmaceuticals Inc | Healthcare | Biotechnology | 3.61% |
| CDNA | CareDx Inc | Healthcare | Diagnostics & Research | 3.32% |
| VCYT | Veracyte Inc | Healthcare | Diagnostics & Research | 3.25% |
| NTLA | Intellia Therapeutics Inc | Healthcare | Biotechnology | 3.16% |
| IONS | Ionis Pharmaceuticals Inc | Healthcare | Biotechnology | 2.78% |
| ADPT | Adaptive Biotechnologies Corp | Healthcare | Biotechnology | 2.71% |
| ABSI | Absci Corp | Healthcare | Biotechnology | 2.64% |
| NRIX | Nurix Therapeutics Inc | Healthcare | Biotechnology | 2.09% |
| SDGR | Schrodinger Inc | Healthcare | Health Information Services | 2.03% |
| CMPS | Compass Pathways Plc | Healthcare | Medical Care Facilities | 1.95% |
| WGS | GeneDx Holdings Corp. | Healthcare | Diagnostics & Research | 1.85% |